医学
特应性皮炎
流行病学
重症监护医学
药物治疗
基础研究
梅德林
皮肤病科
精神科
病理
图书馆学
计算机科学
政治学
法学
作者
Lawrence F. Eichenfield,Stephen Stripling,Selwyn Fung,Amy Cha,Andryann O’Brien,Lawrence A. Schachner
出处
期刊:Pediatric Drugs
[Springer Nature]
日期:2022-06-13
卷期号:24 (4): 293-305
被引量:16
标识
DOI:10.1007/s40272-022-00499-x
摘要
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial number of children and has a significant negative impact on affected patients and their caregivers/families. Recent studies have led to significant evolutions in the understanding of AD pathogenesis, epidemiology, and treatment. The first point of contact for many patients with new-onset AD is usually with their primary care provider or pediatrician. This underscores the importance for pediatricians to understand the basic pathophysiology and current standards of care for AD. This article provides up-to-date information and reviews the basic principles of AD pathophysiology, diagnosis, and management. In addition, the article highlights recent advances in scientific research regarding the mechanisms involved in the pathogenesis of atopic dermatitis that have resulted in the discovery of novel therapeutic targets and the development of targeted biologic therapies with the potential to revolutionize AD therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI